Autonomix Medical Common Stock Performance
| AMIX Stock | 0.53 0.02 3.49% |
The firm shows a Beta (market volatility) of 0.23, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Autonomix Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Autonomix Medical is expected to be smaller as well. At this point, Autonomix Medical Common has a negative expected return of -0.88%. Please make sure to confirm Autonomix Medical's treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Autonomix Medical Common performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Autonomix Medical Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in February 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Last Split Factor 1:20 | Last Split Date 2024-10-25 |
1 | Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology | 10/09/2025 |
2 | How Structural Monitoring Systems Plc stock reacts to weak economy - 2025 Momentum Check Safe Entry Trade Reports - nchmf.gov.vn | 10/20/2025 |
3 | Can Autonomix Medical Inc. stock reach 100 price target - Quarterly Investment Review Daily Growth Stock Tips - newser.com | 11/03/2025 |
4 | Dow Tumbles Over 150 Points Aramark Shares Fall After Q4 Earnings | 11/17/2025 |
5 | Autonomix Medical, Inc. Announces Pricing of 5.0 Million Private Placement Priced At The Market Under Nasdaq Rules | 11/18/2025 |
6 | Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth | 11/26/2025 |
7 | Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium | 12/18/2025 |
8 | Autonomix Medical, Inc. Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment | 12/23/2025 |
| Begin Period Cash Flow | 8.6 M | |
| Total Cashflows From Investing Activities | -14 K |
Autonomix | Build AI portfolio with Autonomix Stock |
Autonomix Medical Relative Risk vs. Return Landscape
If you would invest 119.00 in Autonomix Medical Common on October 4, 2025 and sell it today you would lose (64.94) from holding Autonomix Medical Common or give up 54.57% of portfolio value over 90 days. Autonomix Medical Common is currently does not generate positive expected returns and assumes 9.3654% risk (volatility on return distribution) over the 90 days horizon. In different words, 84% of stocks are less volatile than Autonomix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Autonomix Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Autonomix Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Autonomix Medical Common, and traders can use it to determine the average amount a Autonomix Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0938
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AMIX |
Based on monthly moving average Autonomix Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Autonomix Medical by adding Autonomix Medical to a well-diversified portfolio.
Autonomix Medical Fundamentals Growth
Autonomix Stock prices reflect investors' perceptions of the future prospects and financial health of Autonomix Medical, and Autonomix Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Autonomix Stock performance.
| Return On Equity | -3.52 | ||||
| Return On Asset | -1.59 | ||||
| Current Valuation | (6.89 M) | ||||
| Shares Outstanding | 6.91 M | ||||
| Price To Book | 0.59 X | ||||
| EBITDA | (11.05 M) | ||||
| Net Income | (11.41 M) | ||||
| Total Debt | 1.71 M | ||||
| Book Value Per Share | 1.04 X | ||||
| Cash Flow From Operations | (8.26 M) | ||||
| Earnings Per Share | (4.51) X | ||||
| Market Capitalization | 3.8 M | ||||
| Total Asset | 9.81 M | ||||
| Retained Earnings | (50.38 M) | ||||
| Working Capital | 7.9 M | ||||
About Autonomix Medical Performance
Evaluating Autonomix Medical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Autonomix Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Autonomix Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.05) | (1.10) | |
| Return On Capital Employed | (1.29) | (1.35) | |
| Return On Assets | (1.05) | (1.10) | |
| Return On Equity | (1.27) | (1.33) |
Things to note about Autonomix Medical Common performance evaluation
Checking the ongoing alerts about Autonomix Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Autonomix Medical Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Autonomix Medical generated a negative expected return over the last 90 days | |
| Autonomix Medical has high historical volatility and very poor performance | |
| Autonomix Medical has some characteristics of a very speculative penny stock | |
| Autonomix Medical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (11.41 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Autonomix Medical generates negative cash flow from operations | |
| Autonomix Medical has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Autonomix Medical, Inc. Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment |
- Analyzing Autonomix Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Autonomix Medical's stock is overvalued or undervalued compared to its peers.
- Examining Autonomix Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Autonomix Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Autonomix Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Autonomix Medical's stock. These opinions can provide insight into Autonomix Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.